Johnson & Johnson vs Viatris
Johnson & Johnson (JNJ) and Viatris (VTRS) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $656B
- Last close
- $272.70
- 12 months
- +36.4%
- Market value
- $21.3B
- Last close
- $20.28
- 12 months
- +89.4%
At a glance
- By market value, Johnson & Johnson ($656.5B) is about 31 times Viatris ($21.3B).
- Over the last 12 months Johnson & Johnson's share price moved +36.4% and Viatris's +89.4%; against the S&P 500 that is +25.7 points and +78.7 points.
- In the last 90 days insiders reported 0 open-market purchases at Johnson & Johnson and 0 at Viatris; members of Congress disclosed 4 trades in Johnson & Johnson and 0 in Viatris.
- Next results: Johnson & Johnson Jan 26, 2027, Viatris Feb 24, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Johnson & Johnson JNJNYSE · Pharmaceuticals | Viatris VTRSNASDAQ · Pharmaceuticals | |
|---|---|---|
| Size and profitability | ||
| Market value | $656B | $21.3B |
| Revenue, last fiscal year | $94.2B | $14.3B |
| Net income, last fiscal year | $26.8B | — |
| Net marginNet income as a share of revenue | 28.5% | — |
| Free cash flow | $19.7B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Johnson & Johnson against
Common questions
How do Johnson & Johnson and Viatris compare in size?
Johnson & Johnson has the larger market value: Johnson & Johnson $656B and Viatris $21.3B, at the last close.
Whose share price rose more over the last 12 months, JNJ or VTRS?
Over the last 12 months Johnson & Johnson moved +36.4% and Viatris +89.4%. Past price moves say nothing about the future.
Which has had more insider buying, Johnson & Johnson or Viatris?
Since 2006, Johnson & Johnson insiders reported 25 open-market purchases against 10 for Viatris. These are counts of what was filed, not a view on either stock.
Do members of Congress trade JNJ or VTRS?
In the last 12 months, members of Congress disclosed 26 trades in Johnson & Johnson (JNJ) and 1 in Viatris (VTRS).
When did insiders last buy JNJ and VTRS?
Johnson & Johnson: Dec 1, 2025. Viatris: Mar 10, 2026.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Johnson & Johnson pageViatris pageRare insider trades this weekAll comparisons
https://oqro.io/compare/jnj-vs-vtrs






